AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
BEDAQUILINE
8 registrations across 4 African markets— 7 active
Markets with BEDAQUILINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| RESILIN TABLET; ORAL | 🇿🇼Zimbabwe | MSN LABORATORIES PRIVATE LIMITED | active | Oct 2030 |
| NONE TABLET; ORAL | 🇿🇼Zimbabwe | MACLEODS PHARMACEUTICALS LIMITED | active | Sept 2030 |
| Bedaquiline Tablets 100 mg Film-Coated Tablet | 🇰🇪Kenya | Lupin Limited | active | Jul 2030 |
| Sirturo 20 mg Tablet_ Tablet | 🇳🇬Nigeria | Blooms Pharm Ltd | active | Jun 2030 |
| SIRTURO TABLET; ORAL | 🇿🇼Zimbabwe | JANSSEN-CILAG INTERNATIONAL NV | active | Dec 2027 |
| BEDAQUILINE TABLET, COATED; ORAL | 🇿🇼Zimbabwe | LUPIN LIMITED | active | Dec 2027 |
| Sirturo 100 mg Tablets** Tablet | 🇳🇬Nigeria | Blooms Pharm Ltd | active | Jan 2026 |
| BEDAQUILLINE 100MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
BEDAQUILINE in Africa — Regulatory Overview
BEDAQUILINE is registered across 4 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Zimbabwe, Nigeria, Kenya, Malawi. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 7 (88%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.